ACAD position history
The shares of Acadia Pharmaceuticals (ACAD) that Avidity Partners Management LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 550,000 shares, $9.1M, 0.20% of portfolio
- 2021 Q4: 300,000 shares, $7M, 0.15% of portfolio, Reduce −45.5%
- 2022 Q1: not held, Exit
- 2022 Q2: not held
- 2022 Q3: not held
- 2022 Q4: not held
- 2023 Q1: not held
- 2023 Q2: not held
- 2023 Q3: not held
- 2023 Q4: not held
- 2024 Q1: 588,500 shares, $11M, 0.35% of portfolio, New
- 2024 Q2: not held, Exit
- 2024 Q3: not held
- 2024 Q4: not held
- 2025 Q1: 169,000 shares, $2.8M, 0.54% of portfolio, New
- 2025 Q2: not held, Exit
- 2025 Q3: 144,000 shares, $3.1M, 0.70% of portfolio, New
- 2025 Q4: 106,900 shares, $2.9M, 0.82% of portfolio, Reduce −25.8%
- 2026 Q1: 25,934 shares, $580K, 0.07% of portfolio, Reduce −75.7%
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|